CNS Pharmaceuticals (CNSP) pipeline
TrialRedline tracks 1 clinical trial sponsored by CNS Pharmaceuticals, Inc.: 1 Phase 2.
Company identity checked against sources
1Trials in this database
3Recorded changes · last 12 months
0Recruiting trials
Which trial dates moved later?
CNS Pharmaceuticals clinical trials we track
Check company identity sourcePhase 2 1 trial
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeNCT04762069 | Berubicin, Lomustine | Active not recruiting | 2026-04-27Estimated |
Drugs in these trials
Names as written in the registry records.
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
NCT04762069 · CNS Pharmaceuticals, Inc.
Participant count type changed
Before: Estimated. After: Actual.
Enrollment · participant count changed
Before: 210 participants (planned). After: 252 participants (actual).
Primary completion date changed
Before: 1 Feb 2026. After: 27 Apr 2026.